» Articles » PMID: 3020092

T Lymphocyte Cloning from Rejected Human Kidney Allografts. Growth Frequency and Functional/phenotypic Analysis

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1986 Oct 1
PMID 3020092
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Mechanically harvested lymphocytes invading an irreversibly rejected human kidney allograft were seeded at limiting dilution to calculate the frequency of growing precursors. Optimal growth frequency (1/13) was obtained when Epstein-Barr virus (EBV)-transformed donor B lymphocytes were used as stimulators (D-BLCL) in the presence of interleukin 2 (IL-2). The 55 clones analyzed were all T11+ and T3+, and all expressed DR antigens (45% were T8+ and 55% T4+). Only one clone had a double-labeled (T4+ T8+) surface. All cells proliferated significantly against D-BLCL, although T4+ clones had a significantly shorter average doubling time than T8+ clones. Nearly all T8+ clones were specifically cytotoxic for D-BLCL, while both T4 and T8 did not react against K562, autologous EBV-BLCL, and third-party EBV-BLCL. Detectable IL-2 was found in the culture supernatants of only a minority of clones (all T4+).

Citing Articles

Selection of Epstein-Barr virus specific cytotoxic T lymphocytes can be performed with B lymphoblastoid cell lines created in serum-free media.

Gallot G, Vollant S, Vivien R, Clemenceau B, Ferrand C, Tiberghien P Clin Exp Immunol. 2006; 144(1):158-68.

PMID: 16542378 PMC: 1809631. DOI: 10.1111/j.1365-2249.2006.03035.x.


Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response.

Retiere C, ProdHomme V, Imbert-Marcille B, Bonneville M, Vie H, Hallet M J Virol. 2001; 74(9):3948-52.

PMID: 10756006 PMC: 111908. DOI: 10.1128/jvi.74.9.3948-3952.2000.


The frequency and avidity of committed cytotoxic T lymphocytes (cCTL) for donor HLA class I and class II antigens and their relation with graft vascular disease.

van Besouw N, Loonen E, Vaessen L, Balk A, Claas F, Weimar W Clin Exp Immunol. 1998; 111(3):548-54.

PMID: 9528897 PMC: 1904896. DOI: 10.1046/j.1365-2249.1998.00543.x.


Dual T cell receptor beta chain expression on human T lymphocytes.

Davodeau F, Peyrat M, Romagne F, Necker A, Hallet M, Vie H J Exp Med. 1995; 181(4):1391-8.

PMID: 7699325 PMC: 2191978. DOI: 10.1084/jem.181.4.1391.


Short-term lymphokine stimulation of human peripheral blood mononuclear cells generates cytolytic activity against endothelial cells: involvement of natural killer cells.

Miltenburg A, Daha M, Paul L Immunology. 1988; 65(1):107-12.

PMID: 3263311 PMC: 1385027.


References
1.
Miller G, Shope T, LISCO H, Stitt D, Lipman M . Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Natl Acad Sci U S A. 1972; 69(2):383-7. PMC: 426463. DOI: 10.1073/pnas.69.2.383. View

2.
Roth D, Fuller L, Esquenazi V, Kyriakides G, Pardo V, Miller J . The biologic significance of the mixed lymphocyte kidney culture in humans. Transplantation. 1985; 40(4):376-83. DOI: 10.1097/00007890-198510000-00007. View

3.
Strom T, Tilney N, Carpenter C, BUSCH G . Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med. 1975; 292(24):1257-63. DOI: 10.1056/NEJM197506122922402. View

4.
Strom T, Tilney N, Paradysz J, Bancewicz J, Carpenter C . Cellular components of allograft rejection: identity, specificity, and cytotoxic function of cells infiltrating acutely rejecting allografts. J Immunol. 1977; 118(6):2020-6. View

5.
Loveland B, Hogarth P, Ceredig R, McKenzie I . Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med. 1981; 153(5):1044-57. PMC: 2186155. DOI: 10.1084/jem.153.5.1044. View